 |
FDA Approval Activities for this Drug
Velcade (bortezomib) for Injection, 3.5 mg, Millennium NDA 21-602 Velcade (bortezomib) for Injection, Millennium Pharmaceuticals | Velcade (bortezomib) Injection, Millennium Pharma, Labeling Revision | Velcade (bortezomib) for Injection, Millennium Pharma, Labeling Revision | Velcade (bortezomib) Injection, Millennium Pharma, New or Modified Indication | Velcade (bortezomib) Injection, Millennium Pharma, Efficacy Supp. w/Clinical Data | Velcade (bortezomib) Intravenous Injection, Millennium Pharmaceuticals, Inc., New or Modified Indication | Velcade (bortezomib) Injection, Millennium Pharmaceuticals, Inc., Manufacturing Change or Addition | Velcade (bortezomib) Intravenous Injection, Millennium Pharmaceuticals, Efficacy Supplement with Clinical Data to Support | Velcade (bortezomib) Injection, Millennium Pharmaceuticals, Inc., Labeling Revision
View updates.
|